NCT03777956 - The Effect of Lacosamide in Peripheral Neuropathic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

June 3, 2022

Study Completion Date

June 3, 2022

Conditions

Neuropathic PainNeuropathy;PeripheralNeuropathy, PainfulNeuropathy, DiabeticNeuropathy

Interventions

DRUG

Lacosamide

Lacosamide (50 mg) and identical placebo are given as capsules and taken orally twice a day, up to 200 mg b.i.d.

DRUG

Placebo

Identical placebo are given as capsules and taken orally twice a day.

Trial Locations (1)

Danish Pain Research Center, Aarhus University Hospital, Aarhus